NURIX THERAPEUTICS, INC. Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
NURIX THERAPEUTICS, INC. (NRIX) reported Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property of -$160.00 thousand for the 6-month period ending 2026-05-31, per its 10-Q filed 2026-07-09.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets · last filed 2026-07-09
- NURIX THERAPEUTICS, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2026-05-31 was $0.00.
- NURIX THERAPEUTICS, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2026-02-28 was -$160.00K.
- NURIX THERAPEUTICS, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2025-05-31 was $0.00.
- NURIX THERAPEUTICS, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2025-02-28 was $0.00.
- NURIX THERAPEUTICS, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2025 was -$89.00K.
- NURIX THERAPEUTICS, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2024 was -$31.00K.
- NURIX THERAPEUTICS, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2023 was -$556.00K.
- NURIX THERAPEUTICS, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2022 was -$9.00K.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 3 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 6 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 9 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month |
|---|---|---|---|---|
| 2026-05-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-09 | -$160.00K 10-Q · filed 2026-07-09 | ||
| 2026-02-28 | -$160.00K 10-Q · filed 2026-04-08 | |||
| 2025-11-30 | -$89.00K 10-K · filed 2026-01-28 | |||
| 2025-05-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-09 | $0.00 10-Q · filed 2026-07-09 | -$31.00K derived: sum of 3 quarters · filed 2026-07-09 | -$31.00K derived: sum of 4 quarters · filed 2026-07-09 |
| 2025-02-28 | $0.00 10-Q · filed 2026-04-08 | -$31.00K derived: sum of 2 quarters · filed 2026-04-08 | -$31.00K derived: sum of 3 quarters · filed 2026-04-08 | -$31.00K derived: sum of 4 quarters · filed 2026-04-08 |
| 2024-11-30 | -$31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-28 | -$31.00K derived: sum of 2 quarters · filed 2026-01-28 | -$31.00K derived: sum of 3 quarters · filed 2026-01-28 | -$31.00K 10-K · filed 2026-01-28 |
| 2024-08-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-11 | $0.00 derived: sum of 2 quarters · filed 2024-10-11 | $0.00 10-Q · filed 2024-10-11 | -$12.00K derived: sum of 4 quarters · filed 2026-01-28 |
| 2024-05-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-11 | $0.00 10-Q · filed 2024-07-11 | -$12.00K derived: sum of 3 quarters · filed 2026-01-28 | -$460.00K derived: sum of 4 quarters · filed 2026-01-28 |
| 2024-02-29 | $0.00 10-Q · filed 2024-04-10 | -$12.00K derived: sum of 2 quarters · filed 2026-01-28 | -$460.00K derived: sum of 3 quarters · filed 2026-01-28 | -$500.00K derived: sum of 4 quarters · filed 2026-01-28 |
| 2023-11-30 | -$12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-28 | -$460.00K derived: sum of 2 quarters · filed 2026-01-28 | -$500.00K derived: sum of 3 quarters · filed 2026-01-28 | -$556.00K 10-K · filed 2026-01-28 |
| 2023-08-31 | -$448.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-11 | -$488.00K derived: sum of 2 quarters · filed 2024-10-11 | -$544.00K 10-Q · filed 2024-10-11 | -$544.00K derived: sum of 4 quarters · filed 2025-01-28 |
| 2023-05-31 | -$40.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-11 | -$96.00K 10-Q · filed 2024-07-11 | -$96.00K derived: sum of 3 quarters · filed 2025-01-28 | -$96.00K derived: sum of 4 quarters · filed 2025-01-28 |
| 2023-02-28 | -$56.00K 10-Q · filed 2024-04-10 | -$56.00K derived: sum of 2 quarters · filed 2025-01-28 | -$56.00K derived: sum of 3 quarters · filed 2025-01-28 | -$65.00K derived: sum of 4 quarters · filed 2025-01-28 |
| 2022-11-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-28 | $0.00 derived: sum of 2 quarters · filed 2025-01-28 | -$9.00K derived: sum of 3 quarters · filed 2025-01-28 | -$9.00K 10-K · filed 2025-01-28 |
| 2022-08-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-12 | -$9.00K derived: sum of 2 quarters · filed 2023-10-12 | -$9.00K 10-Q · filed 2023-10-12 | -$9.00K derived: sum of 4 quarters · filed 2023-10-12 |
| 2022-05-31 | -$9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-13 | -$9.00K 10-Q · filed 2023-07-13 | -$9.00K derived: sum of 3 quarters · filed 2023-07-13 | |
| 2022-02-28 | $0.00 10-Q · filed 2023-04-13 | $0.00 derived: sum of 2 quarters · filed 2023-04-13 | ||
| 2021-11-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | -$128.00K 10-K · filed 2023-02-09 | ||
| 2021-08-31 | -$128.00K 10-Q · filed 2022-10-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |